Rockwell Medical, Inc. Profile Avatar - Palmy Investing

Rockwell Medical, Inc.

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the Unite…

Drug Manufacturers - Specialty & Generic
US, Wixom [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Rockwell Medical, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of RMTI's Analysis
CIK: 1041024 CUSIP: 774374300 ISIN: US7743743004 LEI: - UEI: -
Secondary Listings
RMTI has no secondary listings inside our databases.